Literature DB >> 17950138

An emergency medicine approach to neonatal hyperbilirubinemia.

James E Colletti1, Samip Kothari, Samip Kothori, Danielle M Jackson, Kevin P Kilgore, Kelly Barringer.   

Abstract

Jaundice (also known as hyperbilirubinemia) is a yellowish-greenish pigmentation of the sclera and skin caused by an increase in bilirubin production or a defect in bilirubin elimination. Management of hyperbilirubinemia is one of the most common reasons for readmission of a newborn. Prolonged unconjugated hyperbilirubinemia can result in acute bilirubin encephalopathy and eventually develop into chronic bilirubin encephalopathy (kernicterus). Kernicterus, the feared complication of hyperbilirubinemia, was considered almost extinct but has recently re-emerged despite virtual elimination of Rh disease. This review provides a systematic approach to the presentation, evaluation, and management of the jaundiced newborn.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950138     DOI: 10.1016/j.emc.2007.07.007

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  2 in total

1.  Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.

Authors:  Mohsen Saleh Elalfy; Nancy Samir Elbarbary; Heba Wegdan Abaza
Journal:  Eur J Pediatr       Date:  2010-10-06       Impact factor: 3.183

2.  Epidemiology of Hyperbilirubinemia in a Quaternary Pediatric Emergency Department over a Three-Year Period.

Authors:  Zebulon Timmons; Jaci Timmons; Christina Conrad; Tamir Miloh
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.